LLY

1,063.41

+1.23%↑

JNJ

208.24

-0.97%↓

ABBV

224.55

-0.1%↓

UNH

327.03

-1.88%↓

AZN

90.72

-0.15%↓

LLY

1,063.41

+1.23%↑

JNJ

208.24

-0.97%↓

ABBV

224.55

-0.1%↓

UNH

327.03

-1.88%↓

AZN

90.72

-0.15%↓

LLY

1,063.41

+1.23%↑

JNJ

208.24

-0.97%↓

ABBV

224.55

-0.1%↓

UNH

327.03

-1.88%↓

AZN

90.72

-0.15%↓

LLY

1,063.41

+1.23%↑

JNJ

208.24

-0.97%↓

ABBV

224.55

-0.1%↓

UNH

327.03

-1.88%↓

AZN

90.72

-0.15%↓

LLY

1,063.41

+1.23%↑

JNJ

208.24

-0.97%↓

ABBV

224.55

-0.1%↓

UNH

327.03

-1.88%↓

AZN

90.72

-0.15%↓

Search

CareDx Inc

Abierto

SectorSalud

19.34 -1.28

Resumen

Variación precio

24h

Actual

Mínimo

19.19

Máximo

19.88

Métricas clave

By Trading Economics

Ingresos

10M

1.7M

Ventas

13M

100M

P/B

Media del Sector

15.555

76.798

Margen de beneficio

1.674

Empleados

644

EBITDA

11M

6.8M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+13.64% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

274M

1.1B

Apertura anterior

20.62

Cierre anterior

19.34

Noticias sobre sentimiento de mercado

By Acuity

29%

71%

87 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

CareDx Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

17 dic 2025, 23:50 UTC

Acciones populares

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

17 dic 2025, 23:20 UTC

Ganancias

Correction to Micron Logs Sales Jump Article

17 dic 2025, 23:07 UTC

Ganancias

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

17 dic 2025, 21:37 UTC

Ganancias

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

17 dic 2025, 23:53 UTC

Charlas de Mercado

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

17 dic 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

17 dic 2025, 23:06 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

17 dic 2025, 23:05 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

17 dic 2025, 23:04 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

17 dic 2025, 23:03 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

17 dic 2025, 23:02 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

17 dic 2025, 22:59 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

17 dic 2025, 22:57 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

17 dic 2025, 22:56 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

17 dic 2025, 22:55 UTC

Adquisiciones, fusiones, absorciones

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

17 dic 2025, 22:49 UTC

Charlas de Mercado

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

17 dic 2025, 21:58 UTC

Ganancias

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dic 2025, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

17 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

17 dic 2025, 21:46 UTC

Ganancias

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

17 dic 2025, 21:20 UTC

Ganancias

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dic 2025, 21:10 UTC

Ganancias

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

17 dic 2025, 21:05 UTC

Ganancias

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

17 dic 2025, 21:04 UTC

Ganancias

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

17 dic 2025, 21:04 UTC

Ganancias

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

17 dic 2025, 21:03 UTC

Ganancias

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

17 dic 2025, 21:03 UTC

Ganancias

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

17 dic 2025, 21:03 UTC

Ganancias

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

17 dic 2025, 21:02 UTC

Ganancias

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

17 dic 2025, 21:01 UTC

Ganancias

Micron Technology 1Q Rev $13.64B >MU

Comparación entre iguales

Cambio de precio

CareDx Inc Esperado

Precio Objetivo

By TipRanks

13.64% repunte

Estimación a 12 meses

Media 22 USD  13.64%

Máximo 26 USD

Mínimo 18 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CareDx Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

14.77 / 18.49Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

87 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat